NCT01534780

Brief Summary

Clinical, controlled, randomized, prospective study. Ventral hernias between 2(1.5)cm and 7 cm, laparoscopic surgery with intraperitoneal onlay mesh. Three randomization groups of 25 patients giving a total of 75 patients. Mesh is fixated with either Protack, Securestrap or Glubran II. Primary outcome: postoperative pain on the 2nd postoperative day. Secondary outcomes: pain, quality of life, recurrence and adhesions at 1, 6, 12, 24, 36, 48 and 60 months postoperative.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 17, 2012

Completed
1.1 years until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

February 19, 2020

Status Verified

February 1, 2020

Enrollment Period

4.3 years

First QC Date

February 9, 2012

Last Update Submit

February 18, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain

    Dolo Test (VAS)

    1 measurement, 2nd postoperative day

Secondary Outcomes (3)

  • hernia recurrence

    7 measurements, postoperative month 1, 6, 12, 24, 36, 48 and 60

  • quality of life

    7 measurements, postoperative month 1, 6, 12, 24, 36, 48 and 60

  • Pain

    7 measurements, day 1, 3 and 4 and postoperative month 1, 6, 12, 24

Study Arms (3)

fixation with Protack

EXPERIMENTAL
Procedure: laparoscopic ventral herniotomyDevice: Protack

fixation with Securestrap

EXPERIMENTAL
Procedure: laparoscopic ventral herniotomyDevice: Securestrap

fixation with Glubran

EXPERIMENTAL

surgery

Procedure: laparoscopic ventral herniotomyDevice: Glubran

Interventions

Laparoscopy in general anesthesia are performed with placement of Physiomesh intraperitoneally. Fixation of the mesh is performed with 1 of 3 possible devices

Also known as: no other names
fixation with Glubranfixation with Protackfixation with Securestrap
ProtackDEVICE

fixation of mesh with protack

fixation with Protack

fixation of mesh with Securestrap

fixation with Securestrap
GlubranDEVICE

fixation of mesh with Glubran

fixation with Glubran

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ventral hernia 2(1,5) \< dia \> 7 cm
  • danish speaking
  • of sound mind
  • bmi \< 35
  • ASA 3 or less, no contra indication against laparoscopy

You may not qualify if:

  • other size hernias,
  • no danish,
  • bmi \> 35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regional Hospital Horsens

Horsens, 8700, Denmark

Location

Related Publications (1)

  • Harslof S, Krum-Moller P, Sommer T, Zinther N, Wara P, Friis-Andersen H. Effect of fixation devices on postoperative pain after laparoscopic ventral hernia repair: a randomized clinical trial of permanent tacks, absorbable tacks, and synthetic glue. Langenbecks Arch Surg. 2018 Jun;403(4):529-537. doi: 10.1007/s00423-018-1676-z. Epub 2018 May 25.

MeSH Terms

Conditions

Hernia, Ventral

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Sanne S Harsløf, MD

    Regionshospitalet Horsens

    STUDY CHAIR
  • Thorbjørn Sommer, MD, PhD

    Randers Regional Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 9, 2012

First Posted

February 17, 2012

Study Start

April 1, 2013

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

February 19, 2020

Record last verified: 2020-02

Locations